OAd5/3-Cox2-E3-NIS-ADP(-)

N/A

Report date: 2025/03/20 09:43:43

Base Information

Drug NameOAd5/3-Cox2-E3-NIS-ADP(-)
Drug Alias Nameoncolytic adenovirus therapy expressing sodium iodide symporter (Precigen/University of Minnesota/Mayo Clinic)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionSodium/iodide cotransporter stimulants
TargetsSodium/iodide cotransporter
Therapy Area/IndicationsCarcinoma, Pancreatic Ductal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPrecigen Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of MinnesotaMayo ClinicPrecigen Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Pancreatic Ductal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A